Updated on February 21, 2024

·

Created on October 1, 2020

Cerebo

Upcoming Update

Cerebo is a handy, non-invasive, fully computerized system for detecting intracranial hemorrhage within 2 minutes.

Developed By
  1. Bioscan Research
Content Partners
Unknown

Author

Product Description

Cerebo is a handy, non-invasive, fully computerized system for detecting intracranial hemorrhage within 2 minutes. Since it is convenient, it can be easily transported and used on site.  It is completely computerized, so no special skills are required. It is non-invasive, based on NIR spectroscopy, so it can be used multiple times without causing any damage to the patient.

Target Users (Target Impact Group)

Small and Medium-sized Enterprises, Public Sector Agencies

Distributors / Implementing Organizations

This product is distributed by Bioscan Research.

Manufacturing/Building Method

This product is currently in the prototyping phase and not yet manufactured at scale.

Intellectural Property Type

Patent

User Provision Model

The manufacturer has not yet selected its user provision model. Interview with manufacturer

Distributions to Date Status

None

Consumables

None

Detection sensitivity

100%

Indispensable equipment for function (Y/N)

Y

Maintenance or calibration required by user at time of use? (Y/N)

N

Number of Tests Performed

74

Power supply type: Continuous, Recharging only (V, time required, battery life), Other

Rechargeable battery

Time required for procedure (minutes)

2

Design Specifications

The optical method used for nerve monitoring is based on the emission of near-infrared (NIR) from the head surface and the detection of light emitted from a distance of several centimeters.

Product Schematics

Technical Support

Provided by manufacturer.

Replacement Components

N/A

Lifecycle

The product includes a 1-year warranty and has an expected lifetime of 5 - 10 years.

Manufacturer Specified Performance Parameters

The designers aim to reduce the immediate health risks of people that have suffered from traumatic brain injury.

Vetted Performance Status

No testing has been completed. However, Bioscan Research plans to test for laser safety software test, biocompatibility test, and electrostatic discharge immunity test. Interview with manufacturer

Safety

Users must take appropriate precautions when using electrical devices.

Complementary Technical Systems

None

Academic Research and References

Compliance with regulations

None

Evaluation methods

Cerebo was compared with Head CT scan and it was identified that was able to detect 74 hemorrhages with 100% sensitivity.

Other Information

None

Leave a Reply

Explore similar solutions

Agriculture

February 14, 2024

DFA Paper-based liver function test (AIDS, TB)

Read Solution

Implemented by

Diagnostics for all

Agriculture

February 15, 2024

HemoCue WBC DIFF System

Read Solution

Implemented by

HemoCue

Agriculture

February 15, 2024

Q-POC

Read Solution

Implemented by

QuantuMDx

Agriculture

February 15, 2024

PointCheck

Read Solution

Implemented by

Leuko

Agriculture

February 15, 2024

Lifebox Pulse Oximeter

Read Solution

Implemented by

Lifebox

Agriculture

February 20, 2024

Spandan ECG

Read Solution

Implemented by

Sunfox Technologies

Agriculture

February 22, 2024

AyuSynk

Read Solution

Implemented by

AyuSynk

Agriculture

February 23, 2024

iBreastExam

Read Solution

Implemented by

UE LifeSciences

Agriculture

February 23, 2024

Pocket Colposcope

Read Solution

Implemented by

Duke University

Agriculture

February 26, 2024

Zika paper-based rapid diagnostic test

Read Solution

Implemented by

Wyss Institute

All Solutions

Contribute to E4C's Library of Breakthrough Sustainable Development Technology Solutions

Suggest A Solution

Get more information about Solutions Library and its features.

Learn More

Have thoughts on how we can improve?

Give Us Feedback

Join a global community of changemakers.

Become A Member